Cornerstone Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $508K | Sell |
9,691
-60
| -0.6% | -$3.17K | 0.02% | 489 |
|
|
2026
Q1 | $538K | Sell |
9,751
-258
| -3% | -$14K | 0.03% | 432 |
|
|
2025
Q4 | $491K | Sell |
10,009
-258
| -3% | -$12K | 0.03% | 427 |
|
|
2025
Q3 | $443K | Buy |
10,267
+12
| +0.1% | +$469 | 0.02% | 442 |
|
|
2025
Q2 | $394K | Sell |
10,255
-375
| -4% | -$14.3K | 0.02% | 441 |
|
|
2025
Q1 | $412K | Buy |
10,630
+1,091
| +11% | +$39.9K | 0.03% | 412 |
|
|
2024
Q4 | $323K | Sell |
9,539
-964
| -9% | -$34.7K | 0.02% | 446 |
|
|
2024
Q3 | $429K | Sell |
10,503
-877
| -8% | -$35.9K | 0.03% | 387 |
|
|
2024
Q2 | $438K | Buy |
11,380
+97
| +0.9% | +$4.08K | 0.03% | 352 |
|
|
2024
Q1 | $484K | Sell |
11,283
-3,067
| -21% | -$126K | 0.04% | 332 |
|
|
2023
Q4 | $532K | Sell |
14,350
-656
| -4% | -$23.6K | 0.05% | 312 |
|
|
2023
Q3 | $544K | Buy |
15,006
+59
| +0.4% | +$2.09K | 0.05% | 283 |
|
|
2023
Q2 | $533K | Sell |
14,947
-7
| -0% | -$251 | 0.05% | 294 |
|
|
2023
Q1 | $532K | Buy |
+14,954
| New | +$523K | 0.05% | 276 |
|
|
2022
Q3 | $424K | Buy |
14,402
+300
| +2% | +$11.4K | 0.05% | 291 |
|
|
2022
Q2 | $767K | Buy |
14,102
+8,592
| +156% | +$474K | 0.09% | 194 |
|
|
2022
Q1 | $300K | Sell |
5,510
-433
| -7% | -$23.5K | 0.03% | 366 |
|
|
2021
Q4 | $327K | Buy |
5,943
+1,386
| +30% | +$72.1K | 0.03% | 366 |
|
|
2021
Q3 | $218K | Buy |
4,557
+100
| +2% | +$5.02K | 0.02% | 417 |
|
|
2021
Q2 | $222K | Sell |
4,457
-2,479
| -36% | -$119K | 0.02% | 428 |
|
|
2021
Q1 | $309K | Sell |
6,936
-182
| -3% | -$8.26K | 0.04% | 346 |
|
|
2020
Q4 | $327K | Sell |
7,118
-478
| -6% | -$22K | 0.04% | 318 |
|
|
2020
Q3 | $357K | Buy |
7,596
+3,149
| +71% | +$158K | 0.05% | 269 |
|
|
2020
Q2 | $227K | Buy |
4,447
+169
| +4% | +$8.67K | 0.04% | 336 |
|
|
2020
Q1 | $203K | Sell |
4,278
-274
| -6% | -$14.6K | 0.04% | 326 |
|
|
2019
Q4 | $267K | Sell |
4,552
-619
| -12% | -$34.4K | 0.04% | 286 |
|
|
2019
Q3 | $276K | Sell |
5,171
-926
| -15% | -$47.6K | 0.05% | 277 |
|
|
2019
Q2 | $304K | Buy |
6,097
+332
| +6% | +$16.7K | 0.05% | 279 |
|
|
2019
Q1 | $324K | Sell |
5,765
-537
| -9% | -$26.8K | 0.04% | 366 |
|
|
2018
Q4 | $299K | Sell |
6,302
-398,312
| -98% | -$19.6M | 0.06% | 260 |
|
|
2018
Q3 | $12.5M | Buy |
404,614
+120,880
| +43% | +$6.14M | 0.16% | 144 |
|
|
2018
Q2 | $8.84M | Buy |
283,734
+276,849
| +4,021% | +$13.9M | 0.1% | 215 |
|
|
2018
Q1 | $333K | Sell |
6,885
-1,980
| -22% | -$92.2K | 0.06% | 279 |
|
|
2017
Q4 | $416K | Sell |
8,865
-1,101
| -11% | -$50.9K | 0.08% | 253 |
|
|
2017
Q3 | $504K | Buy |
9,966
+4,413
| +79% | +$224K | 0.1% | 199 |
|
|
2017
Q2 | $292K | Buy |
5,553
+429
| +8% | +$22.9K | 0.07% | 290 |
|
|
2017
Q1 | $267K | Buy |
+5,124
| New | +$260K | 0.07% | 268 |
|
Other funds holding GSK
JEST
Cornerstone Wealth Management's GSK Position: Q2 2026 in Review
Cornerstone Wealth Management reduced its GSK (GSK) stake by 0.62% in Q2 2026, selling an estimated $3.17K and leaving 9,691 shares worth $508K. The position accounts for 0.02% of the portfolio, ranked #489.
Cornerstone Wealth Management first reported a position in GSK in Q1 2017 and has held it in 37 quarters since. The position peaked at $12.5M in Q3 2018. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Cornerstone Wealth Management held 9,691 shares of GSK worth $508K as of Q2 2026.
- Cornerstone Wealth Management sold 60 GSK shares in Q2 2026, an estimated $3.17K.
- GSK made up 0.02% of Cornerstone Wealth Management's portfolio in Q2 2026, its #489 holding.
- Cornerstone Wealth Management first reported a position in GSK in Q1 2017 and has held it in 37 quarters since.
- Cornerstone Wealth Management's GSK position peaked at $12.5M in Q3 2018.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.